Literature DB >> 17435909

The influence of genetics on nicotine dependence and the role of pharmacogenetics in treating the smoking habit.

José Miguel Chatkin1.   

Abstract

Despite the considerable efforts made in the fight against smoking in the last decades, there are still substantial numbers of people who, in full knowledge of the health hazards, begin smoking or continue smoking. Recent studies have focused on the genetic bases of the nicotine addiction. Various genetic polymorphisms have been associated with smoking. However, environmental factors have also been shown to play a role. In this review, we present some of the principal data collected in genetic studies of smoking behavior. The results obtained through this line of research will eventually aid clinicians in individualizing the type, dosage and duration of treatment for patients with nicotine dependence in accordance with the genotype of each smoker, thereby maximizing the efficacy of the proposed treatment regimen.

Entities:  

Mesh:

Year:  2006        PMID: 17435909     DOI: 10.1590/s1806-37132006000600016

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN: 1806-3713            Impact factor:   2.624


  2 in total

1.  Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline.

Authors:  Paulo Roberto Xavier Tomaz; Mariana Soares Kajita; Juliana Rocha Santos; Jaqueline Scholz; Tânia Ogawa Abe; Patrícia Viviane Gaya; José Eduardo Krieger; Alexandre Costa Pereira; Paulo Caleb Júnior Lima Santos
Journal:  Eur J Clin Pharmacol       Date:  2019-08-11       Impact factor: 2.953

2.  Nicotine dependence and smoking habits in patients with head and neck cancer.

Authors:  Adriana Ávila de Almeida; Celso Muller Bandeira; Antonio José Gonçalves; Alberto José Araújo
Journal:  J Bras Pneumol       Date:  2014 May-Jun       Impact factor: 2.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.